GENE ONLINE|News &
Neuro, Pain, and Cancer Top the List at JPM 2025 Healthcare Conference
The 2025 J.P. Morgan Healthcare Conference highlights breakthroughs, strategic partnerships, and innovations in neurodegenerative diseases, cancer, and pain management.
The J.P. Morgan Healthcare Conference 2025 has returned to San Francisco, setting the stage for the year in life sciences with a mix of challenges and opportunities. While the industry saw significant layoffs from companies like Intellia, Galapagos, and Passage Bio, pre-conference deals offered a promising start. Lonza’s Synaffix secured a $1.3 billion ADC partnership … Neuro, Pain, and Cancer Top the List at JPM 2025 Healthcare Conference Read More » To access this post, you must purchase Individual Subscriber Yearly or Enterprise Subscriber.
GO Prime with only $1.49 now
LATEST
Definium’s Psychedelic Anxiety Drug DT120 Moves Closer to the Mainstream With a Phase 3 Win
2026-08-14
JAMA Network Open Study Links Agent Orange and Burn Pit Exposure to Veteran Health Outcomes
2026-08-14
EVENT
2026-10-20
AusBiotech 2026 (20-23 Oct, Queensland) (Australia biotech & investment)
Queensland, Australia
